CN108904535A - 一种鹿角胶制备方法 - Google Patents
一种鹿角胶制备方法 Download PDFInfo
- Publication number
- CN108904535A CN108904535A CN201810900157.8A CN201810900157A CN108904535A CN 108904535 A CN108904535 A CN 108904535A CN 201810900157 A CN201810900157 A CN 201810900157A CN 108904535 A CN108904535 A CN 108904535A
- Authority
- CN
- China
- Prior art keywords
- glue
- glue juice
- basin
- juice
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003292 glue Substances 0.000 title claims abstract description 307
- 241000282994 Cervidae Species 0.000 title claims abstract description 76
- 238000002360 preparation method Methods 0.000 title claims abstract description 43
- 239000006260 foam Substances 0.000 claims abstract description 38
- 238000000605 extraction Methods 0.000 claims abstract description 21
- 238000000034 method Methods 0.000 claims abstract description 20
- 230000008569 process Effects 0.000 claims abstract description 17
- 238000002203 pretreatment Methods 0.000 claims abstract description 13
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 214
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 92
- 238000001914 filtration Methods 0.000 claims description 39
- 244000068988 Glycine max Species 0.000 claims description 26
- 235000010469 Glycine max Nutrition 0.000 claims description 26
- 235000019991 rice wine Nutrition 0.000 claims description 26
- 239000011435 rock Substances 0.000 claims description 26
- 239000002244 precipitate Substances 0.000 claims description 24
- 239000000047 product Substances 0.000 claims description 23
- 239000013049 sediment Substances 0.000 claims description 15
- 238000010438 heat treatment Methods 0.000 claims description 14
- 238000004090 dissolution Methods 0.000 claims description 13
- 229920000297 Rayon Polymers 0.000 claims description 12
- 238000005520 cutting process Methods 0.000 claims description 12
- 229920001971 elastomer Polymers 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 239000004033 plastic Substances 0.000 claims description 12
- 239000008213 purified water Substances 0.000 claims description 12
- 238000000926 separation method Methods 0.000 claims description 12
- 238000007711 solidification Methods 0.000 claims description 12
- 230000008023 solidification Effects 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- 239000000872 buffer Substances 0.000 claims description 11
- 238000004806 packaging method and process Methods 0.000 claims description 2
- 239000008363 phosphate buffer Substances 0.000 claims description 2
- 238000004134 energy conservation Methods 0.000 abstract description 2
- 230000007613 environmental effect Effects 0.000 abstract description 2
- 239000012535 impurity Substances 0.000 abstract description 2
- 238000011084 recovery Methods 0.000 abstract description 2
- 239000007789 gas Substances 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000001376 precipitating effect Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 4
- 210000003056 antler Anatomy 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- XPFJYKARVSSRHE-UHFFFAOYSA-K trisodium;2-hydroxypropane-1,2,3-tricarboxylate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].[Na+].[Na+].OC(=O)CC(O)(C(O)=O)CC(O)=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O XPFJYKARVSSRHE-UHFFFAOYSA-K 0.000 description 3
- HFEWAGKDZLEFCT-UHFFFAOYSA-L C(C)C(COP(=O)(OCC(CCCC)CC)[O-])CCCC.P(=O)(O)([O-])O.[Na+].[Na+] Chemical compound C(C)C(COP(=O)(OCC(CCCC)CC)[O-])CCCC.P(=O)(O)([O-])O.[Na+].[Na+] HFEWAGKDZLEFCT-UHFFFAOYSA-L 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000010835 comparative analysis Methods 0.000 description 2
- QSLMXDUZJAJNJO-UHFFFAOYSA-L disodium hydrogen phosphate phosphoric acid Chemical compound [Na+].[Na+].OP(O)(O)=O.OP(O)(O)=O.OP([O-])([O-])=O QSLMXDUZJAJNJO-UHFFFAOYSA-L 0.000 description 2
- 238000005265 energy consumption Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- XONPDZSGENTBNJ-UHFFFAOYSA-N molecular hydrogen;sodium Chemical compound [Na].[H][H] XONPDZSGENTBNJ-UHFFFAOYSA-N 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 1
- 241000282985 Cervus Species 0.000 description 1
- 241000283007 Cervus nippon Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000000337 buffer salt Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Toxicology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Reproductive Health (AREA)
- Pain & Pain Management (AREA)
- Pregnancy & Childbirth (AREA)
- Biomedical Technology (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Jellies, Jams, And Syrups (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810900157.8A CN108904535B (zh) | 2018-08-09 | 2018-08-09 | 一种鹿角胶制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810900157.8A CN108904535B (zh) | 2018-08-09 | 2018-08-09 | 一种鹿角胶制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108904535A true CN108904535A (zh) | 2018-11-30 |
CN108904535B CN108904535B (zh) | 2022-01-25 |
Family
ID=64394665
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810900157.8A Active CN108904535B (zh) | 2018-08-09 | 2018-08-09 | 一种鹿角胶制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108904535B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110279715A (zh) * | 2019-07-26 | 2019-09-27 | 西藏月王药诊生态藏药科技有限公司 | 一种藏药牦牛角胶的炮制方法以及凝胶剂及其应用 |
CN111184211A (zh) * | 2019-12-26 | 2020-05-22 | 苏州红冠庄国药股份有限公司 | 一种鹿角胶及其制备方法和应用方法 |
CN111297903A (zh) * | 2020-03-24 | 2020-06-19 | 中科花鹿农业发展有限公司 | 一种鹿角胶及其工业制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101559078A (zh) * | 2009-05-25 | 2009-10-21 | 山东华信制药集团股份有限公司 | 一种胶剂系列药品 |
CN107397185A (zh) * | 2017-08-31 | 2017-11-28 | 湖南东健药业有限公司 | 一种鹿角胶核桃糕及其制备方法 |
-
2018
- 2018-08-09 CN CN201810900157.8A patent/CN108904535B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101559078A (zh) * | 2009-05-25 | 2009-10-21 | 山东华信制药集团股份有限公司 | 一种胶剂系列药品 |
CN107397185A (zh) * | 2017-08-31 | 2017-11-28 | 湖南东健药业有限公司 | 一种鹿角胶核桃糕及其制备方法 |
Non-Patent Citations (2)
Title |
---|
YOOHEON PARK ET AL.: "Hematopoietic effect of deer antler extract fermented by Bacillus subtilis on murine marrow cells", 《NUTR RES PRACT》 * |
闫晓侠等: "鹿肉的加工及利用现状", 《肉类研究》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110279715A (zh) * | 2019-07-26 | 2019-09-27 | 西藏月王药诊生态藏药科技有限公司 | 一种藏药牦牛角胶的炮制方法以及凝胶剂及其应用 |
CN111184211A (zh) * | 2019-12-26 | 2020-05-22 | 苏州红冠庄国药股份有限公司 | 一种鹿角胶及其制备方法和应用方法 |
CN111297903A (zh) * | 2020-03-24 | 2020-06-19 | 中科花鹿农业发展有限公司 | 一种鹿角胶及其工业制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN108904535B (zh) | 2022-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108904535A (zh) | 一种鹿角胶制备方法 | |
CN105063139B (zh) | 一种用于醒酒的沙棘籽多肽的制备方法 | |
CN105085697A (zh) | 一种小球藻多糖的提取方法 | |
CN109846940A (zh) | 一种黄精多糖提取物及其提取方法和用途 | |
CN103923201B (zh) | 一种海马活性糖蛋白的制备方法 | |
CN106119327A (zh) | 从海藻中提取低聚肽制作海藻低聚肽粉的方法 | |
CN102273625B (zh) | 西洋参无糖阿胶片及其生产工艺 | |
CN104292352B (zh) | 一种杜仲精粉、杜仲多糖及杜仲胶联产提取分离方法 | |
CN104762134A (zh) | 一种桂花发酵型烟用香料及其制备方法 | |
CN106117380B (zh) | 一种香菇多糖的提取方法 | |
CN106893000A (zh) | 一种白芨胶提取方法 | |
CN109527270A (zh) | 水蛭特异性营养诱导液及天然水蛭素的提取方法 | |
CN102775466A (zh) | 富硒酵母中含硒蛋白的制备方法 | |
CN106478831A (zh) | 一种牡丹多糖及其制备方法和应用 | |
CN104041830B (zh) | 一种增强免疫功能的鱼皮胶原肽复方制品及其制备方法 | |
CN109355340A (zh) | 一种具有高热稳定性海参抗氧化螯合肽的制备方法 | |
CN102382181B (zh) | 从香菇中提取具有抗氧化降血糖作用的活性蛋白的方法 | |
CN107793492A (zh) | 一种火麻仁多糖的提取方法 | |
CN103951737A (zh) | 一种从海藻中提取亲糖蛋白的方法 | |
CN103767888B (zh) | 浒苔多糖在用于制备化妆品添加剂中的应用 | |
CN109010370A (zh) | 一种阿胶的提取工艺 | |
CN105732837B (zh) | 一种除蛋白质去重金属的鲍鱼脏器多糖粉的制备方法 | |
CN104450843B (zh) | 一种快速从河蚬中分离提取多肽多糖的方法 | |
JPH1075750A (ja) | にんにく系健康飲料 | |
CN107814851A (zh) | 贻贝多糖的提取工艺 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: No.47 Zhongxing Street, Lincheng Economic Development Zone, Xingtai City, Hebei Province 054300 Applicant after: HEBEI JUNLIN PHARMACEUTICAL Co.,Ltd. Address before: 054300 North Ring East Road, Lincheng Town, Lincheng County, Xingtai City, Hebei Province Applicant before: HEBEI JUNLIN PHARMACEUTICAL Co.,Ltd. |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A preparation method of antler gum Effective date of registration: 20220519 Granted publication date: 20220125 Pledgee: Hebei Xingtai Rural Commercial Bank Co.,Ltd. Pledgor: HEBEI JUNLIN PHARMACEUTICAL CO.,LTD. Registration number: Y2022130000032 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20220125 Pledgee: Hebei Xingtai Rural Commercial Bank Co.,Ltd. Pledgor: HEBEI JUNLIN PHARMACEUTICAL CO.,LTD. Registration number: Y2022130000032 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A method for preparing deer antler adhesive Granted publication date: 20220125 Pledgee: Hebei Xingtai Rural Commercial Bank Co.,Ltd. Pledgor: HEBEI JUNLIN PHARMACEUTICAL CO.,LTD. Registration number: Y2024980016761 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |